We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PTIXW market cap is 88.7k. The company's latest EPS is USD -1.1274 and P/E is -1.21.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -656k | -739k | -1.14M | -1.43M | -1.21M |
| Net Income | -602k | -718k | -1.21M | -1.4M | -1.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.09M | -2.55M | -4.14M | -3.56M | -4.53M |
| Net Income | -1.75M | -2.55M | -4.52M | -3.56M | -5M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.04M | 7.67M | 6.92M | 5.43M | 4.32M |
| Total Liabilities | 1.12M | 1.25M | 1.51M | 1.28M | 655k |
| Total Equity | 6.92M | 6.41M | 5.41M | 4.15M | 3.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 842k | 879k | 11.06M | 8.04M | 4.32M |
| Total Liabilities | 1.48M | 2.03M | 1.12M | 1.12M | 655k |
| Total Equity | -634k | -1.15M | 9.94M | 6.92M | 3.67M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.99M | -372k | -1.9M | -2.56M | -3.7M |
| Investing | 1.6M | 295k | 1.91M | 2.5M | 4.78M |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -488k | -1.35M | -2.8M | -1.99M | -3.7M |
| Investing | 250k | N/A | -9.91M | 1.6M | 4.78M |
| Financing | 670k | 1.22M | 12.58M | N/A | N/A |
| Market Cap | 88.7k |
| Price to Earnings Ratio | -1.21 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.68 |
| Price to Book Ratio | 1.64 |
| Dividend Yield | - |
| Shares Outstanding | 4.44M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.02 (54.75%) |
| Company Name | Protagenic Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.protagenic.com |
| Industry | books: pubg, pubg & printing (2731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
